Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Septo-optic dysplasia].

L Martínez-Sánchez1, A Arce, J Caritg-Bosch

  • 1Servicio de Pediatría, Seccion de Endocrinología, Unidad Integrada Hospital Sant Joan de Déu, Esplugues de Ll. (Barcelona), España. 33050lms@com.es

Revista De Neurologia
|October 10, 2002
PubMed
Summary

Early diagnosis of Septo-Optic Dysplasia (SOD) is crucial for treating hepatic and neurological damage. This rare condition involves optic nerve hypoplasia, brain malformations, and hormonal dysfunction, requiring prompt hormone replacement therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous diphtheria in a child returning from visiting friends & relatives in Burkina Faso: a case report.

Infection·2025
Same author

Assessment of food waste hydrochar as a soil amendment: Effects on soil properties, plant growth and stress response.

Waste management (New York, N.Y.)·2025
Same author

European guidelines on diagnosis and treatment of phenylketonuria: First revision.

Molecular genetics and metabolism·2025
Same author

Oral anticoagulant treatment in atrial fibrillation: the AFIRMA real-world study using natural language processing and machine learning.

Revista clinica espanola·2024
Same author

Defining tetrahydrobiopterin responsiveness in phenylketonuria: Survey results from 38 countries.

Molecular genetics and metabolism·2021
Same author

Correction to: PKU dietary handbook to accompany PKU guidelines.

Orphanet journal of rare diseases·2020

Area of Science:

  • Pediatric Endocrinology
  • Neuro-ophthalmology
  • Developmental Pediatrics

Background:

  • Septo-optic dysplasia (SOD), first described in 1956, is characterized by optic nerve hypoplasia, midline brain malformations, and variable hypothalamohypophysial dysfunction.
  • It represents an infrequent yet treatable cause of significant hepatic and neurological damage in infants.
  • Early diagnosis and initiation of hormone replacement therapy are critical for managing SOD.

Observation:

  • This report details a female infant diagnosed with SOD following the identification of cholestatic jaundice.
  • The patient presented with all three core components: hypothalamohypophysial dysfunction, bilateral optic nerve hypoplasia, and midline brain malformations including transparent septum dysplasia.
  • Clinical manifestations included hypernatremic dehydration due to insipid diabetes, nystagmus, and severe psychomotor retardation.

Related Experiment Videos

Findings:

  • Despite the recognized importance of early diagnosis, SOD is often identified late, increasing the risk of mortality and brain damage.
  • Neonatal indicators such as hypoglycemia, micropenis with cryptorchidism, jaundice, and insipid diabetes can suggest SOD.
  • Nystagmus and neurological deficits may manifest later, with definitive diagnosis confirmed by neuroimaging (CT/MRI) and hormonal studies.

Implications:

  • Delayed diagnosis of SOD in neonates with hypopituitarism can lead to fatal outcomes or irreversible neurological damage.
  • Recognizing early clinical clues like neonatal hypoglycemia or jaundice is vital for timely intervention.
  • Prompt diagnosis and management, including hormone replacement, can mitigate the severe consequences of SOD.